SiteOne Therapeutics


SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch, and pain.

Industries

Employees

11-50

Links


Org chart

John V. Mulcahy
President & CEO
Collapse
John C. Hunter
Chief Scientific Officer
Yizhao Li
Director Of Development Operations
Diana Chung
Chief Development Officer (cdo)
Evelin Becker Reina
Administrative Assistant
Brian Wakabayashi
Vice President, Financial Planning And Analysis

Board & advisors

Rick Orr
Director
Will Price
Director
Brendan Canning
Scientific Advisor
Peter Dicpinigaitis
Scientific Advisor
Anthony Ford
Scientific Advisor
Bradley J. Undem
Scientific Advisor
Stephen G. Waxman
Scientific Advisor
Frank Porreca
Scientific Advisor
Michael C. Rowbotham
Scientific Advisor
Gary D. Novack
Scientific Advisor
Stephen Wexler
Scientific Advisor


Offices